Journal article
Risks of Pneumonia in Patients with Asthma Taking Inhaled Corticosteroids
Abstract
RATIONALE: Inhaled corticosteroids (ICS) are the mainstay of asthma treatment. Studies in chronic obstructive pulmonary disease reported increased rates of pneumonia with ICS. Concerns exist about an increased pneumonia risk in patients with asthma taking ICS.
OBJECTIVES: To evaluate the risks of pneumonia in patients with asthma taking ICS.
Authors
O'Byrne PM; Pedersen S; Carlsson L-G; Radner F; Thorén A; Peterson S; Ernst P; Suissa S
Journal
American Journal of Respiratory and Critical Care Medicine, Vol. 183, No. 5, pp. 589–595
Publisher
American Thoracic Society
Publication Date
March 1, 2011
DOI
10.1164/rccm.201005-0694oc
ISSN
1073-449X
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Administration, InhalationAdolescentAdrenal Cortex HormonesAdultAgedAndrostadienesAsthmaBronchodilator AgentsBudesonideCausalityChildChild, PreschoolComorbidityDouble-Blind MethodFemaleFluticasoneHumansIncidenceMaleMiddle AgedPneumoniaProportional Hazards ModelsRandomized Controlled Trials as TopicRetrospective StudiesRisk FactorsYoung Adult